Leapfrog Bio
Phase 1Leapfrog Bio is developing targeted therapies for cancers driven by genetic mutations that cannot be treated with conventional approaches.
Founded
2021
Focus
Synthetic BiologyBiologics
About
Leapfrog Bio is developing targeted therapies for cancers driven by genetic mutations that cannot be treated with conventional approaches.
Funding History
2Total raised: $18M
Series A$15MUndisclosedMay 15, 2021
Seed$3MUndisclosedAug 15, 2019
Company Info
TypePrivate
Founded2021
LocationSan Diego, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile